Medizinische Universität Graz - Research portal

Go directly to the nagivation.
Go directly to the content.

Navigation/Search

Selected Publication:

SHR Neuro Cancer Cardio Lipid Metab Microb

Greimel, ER; Kuljanic Vlasic, K; Waldenstrom, AC; Duric, VM; Jensen, PT; Singer, S; Chie, W; Nordin, A; Bjelic Radisic, V; Wydra, D; European Organization for Research and Treatment of Cancer Quality-of-Life Group.
The European Organization for Research and Treatment of Cancer (EORTC) Quality-of-Life questionnaire cervical cancer module: EORTC QLQ-CX24.
CANCER. 2006; 107(8): 1812-1822. Doi: 10.1002/cncr.22217 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

Leading authors Med Uni Graz: Greimel Elfriede Renate
Co-authors Med Uni Graz: Bjelic-Radisic Vesna
Altmetrics:
Dimensions Citations:
Plum Analytics:
Scite (citation analytics):
Abstract:: BACKGROUND. The authors report on the development and validation of a cervical cancer module for the European Organization for Research and Treatment of Cancer (EORTC) Quality-of-Life (QoL) questionnaire (QLQ), which was designed to assess disease-specific and treatment-specific aspects of QoL in patients with cervical cancer. METHODS. The cervical cancer module (EORTC QLQ-CX24) was developed in a multicultural, multidisciplinary setting to supplement the EORTC QLQ-C30 core questionnaire. The QLQ-C30 and the cervical cancer module were administered to 346 patients with cervical cancer who underwent radical hysterectomy and received radiotherapy and chemotherapy. Psychometric analyses were performed by using data from 2 independent samples. RESULTS. The QLQ-CX24 consists of 3 multiitem scales and 5 single-item scales. Multitrait scaling analyses revealed high internal consistencies for the subscales with Cronbach alpha coefficients ranging from .72 to .87 (Symptom Experience,.72; Body Image, .86; Sexual/Vaginal Functioning,.87). Convergent and discriminant validity were fulfilled with scaling errors below 3%. The QLQ-CX24 was capable of discriminating between clinical subgroups. All items exhibited good compliance with < 3% missing values. Most patients completed the EORTC QLQ-C30 and the QLQ-CX24 in < 15 minutes (86%), and many did not require any assistance to complete the questionnaires (65%). CONCLUSIONS. The current psychometric analyses supported the content and construct validity and the reliability of the EORTC QLQ-CX24 module. This newly developed module is a useful instrument for assessing the QoL of patients who are treated for cervical cancer both in clinical trials and in clinical practice. (c) 2006 American Cancer Society.
Find related publications in this database (using NLM MeSH Indexing): Adult -; Aged -; Female -; Humans -; Karnofsky Performance Status -; Middle Aged -; Psychometrics -; Quality of Life -; Questionnaires -; Reproducibility of Results -; Uterine Cervical Neoplasms - psychology
Find related publications in this database (Keywords): quality of life; patient-reported outcome; questionnaire development; European Organization for Research and Treatment of Cancer; reliability; validity; cervical cancer